19/03/2026
🚨 PANCREAS TRANSPLANT FOR TYPE 1 DIABETES… but not how you think.
I’ve been listening to the latest episode of the Risely Health Podcast with Lauren Bongiorno 🎧 …and WOW — this one is worth your time.
They speak with real participants from the Eledon trial in the US, looking at islet cell transplantation + a new targeted immunotherapy.
Let’s break this down 👇
🧬 This isn’t a full pancreas transplant
→ It’s insulin-producing cells (islets) infused into the liver
💊 The difference?
→ A newer anti-rejection therapy (designed to be more targeted, less toxic)
📊 Early reports are showing:
→ Some participants reducing or even stopping insulin (short-term)
→ The body producing insulin again
→ More “natural” glucose responses
Now… here’s the part I really want you to hear 👇
⚠️ This is NOT a cure (yet)
⚠️ Very small numbers
⚠️ Short follow-up
⚠️ Still requires immune therapy
But…
✨ It gives us a glimpse into what could be possible in the future of type 1 diabetes care
As a clinician working in this space every day — this is the kind of research that makes you stop and think:
👉 Are we moving closer to changing the trajectory of type 1 diabetes?
👉 What would this mean for access, equity, and real-world care?
🎧 If you have type 1 diabetes, work in diabetes, or just love staying across emerging tech — go listen.
And I’d LOVE to know your thoughts after 👇
For decades, people living with Type 1 diabetes have asked the same question: what would life look like if my body made insulin again? In today’s episode, Lauren sits down with Katie Beth Hand (13 years with T1D) and Chris (diagnosed at 10 months old, living 35 years with T1D), two of only ten par...